Cargando…

Joint Modeling of RNAseq and Radiomics Data for Glioma Molecular Characterization and Prediction

RNA sequencing (RNAseq) is a recent technology that profiles gene expression by measuring the relative frequency of the RNAseq reads. RNAseq read counts data is increasingly used in oncologic care and while radiology features (radiomics) have also been gaining utility in radiology practice such as d...

Descripción completa

Detalles Bibliográficos
Autores principales: Shboul, Zeina A., Diawara, Norou, Vossough, Arastoo, Chen, James Y., Iftekharuddin, Khan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416908/
https://www.ncbi.nlm.nih.gov/pubmed/34490297
http://dx.doi.org/10.3389/fmed.2021.705071
_version_ 1783748279065903104
author Shboul, Zeina A.
Diawara, Norou
Vossough, Arastoo
Chen, James Y.
Iftekharuddin, Khan M.
author_facet Shboul, Zeina A.
Diawara, Norou
Vossough, Arastoo
Chen, James Y.
Iftekharuddin, Khan M.
author_sort Shboul, Zeina A.
collection PubMed
description RNA sequencing (RNAseq) is a recent technology that profiles gene expression by measuring the relative frequency of the RNAseq reads. RNAseq read counts data is increasingly used in oncologic care and while radiology features (radiomics) have also been gaining utility in radiology practice such as disease diagnosis, monitoring, and treatment planning. However, contemporary literature lacks appropriate RNA-radiomics (henceforth, radiogenomics) joint modeling where RNAseq distribution is adaptive and also preserves the nature of RNAseq read counts data for glioma grading and prediction. The Negative Binomial (NB) distribution may be useful to model RNAseq read counts data that addresses potential shortcomings. In this study, we propose a novel radiogenomics-NB model for glioma grading and prediction. Our radiogenomics-NB model is developed based on differentially expressed RNAseq and selected radiomics/volumetric features which characterize tumor volume and sub-regions. The NB distribution is fitted to RNAseq counts data, and a log-linear regression model is assumed to link between the estimated NB mean and radiomics. Three radiogenomics-NB molecular mutation models (e.g., IDH mutation, 1p/19q codeletion, and ATRX mutation) are investigated. Additionally, we explore gender-specific effects on the radiogenomics-NB models. Finally, we compare the performance of the proposed three mutation prediction radiogenomics-NB models with different well-known methods in the literature: Negative Binomial Linear Discriminant Analysis (NBLDA), differentially expressed RNAseq with Random Forest (RF-genomics), radiomics and differentially expressed RNAseq with Random Forest (RF-radiogenomics), and Voom-based count transformation combined with the nearest shrinkage classifier (VoomNSC). Our analysis shows that the proposed radiogenomics-NB model significantly outperforms (ANOVA test, p < 0.05) for prediction of IDH and ATRX mutations and offers similar performance for prediction of 1p/19q codeletion, when compared to the competing models in the literature, respectively.
format Online
Article
Text
id pubmed-8416908
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84169082021-09-05 Joint Modeling of RNAseq and Radiomics Data for Glioma Molecular Characterization and Prediction Shboul, Zeina A. Diawara, Norou Vossough, Arastoo Chen, James Y. Iftekharuddin, Khan M. Front Med (Lausanne) Medicine RNA sequencing (RNAseq) is a recent technology that profiles gene expression by measuring the relative frequency of the RNAseq reads. RNAseq read counts data is increasingly used in oncologic care and while radiology features (radiomics) have also been gaining utility in radiology practice such as disease diagnosis, monitoring, and treatment planning. However, contemporary literature lacks appropriate RNA-radiomics (henceforth, radiogenomics) joint modeling where RNAseq distribution is adaptive and also preserves the nature of RNAseq read counts data for glioma grading and prediction. The Negative Binomial (NB) distribution may be useful to model RNAseq read counts data that addresses potential shortcomings. In this study, we propose a novel radiogenomics-NB model for glioma grading and prediction. Our radiogenomics-NB model is developed based on differentially expressed RNAseq and selected radiomics/volumetric features which characterize tumor volume and sub-regions. The NB distribution is fitted to RNAseq counts data, and a log-linear regression model is assumed to link between the estimated NB mean and radiomics. Three radiogenomics-NB molecular mutation models (e.g., IDH mutation, 1p/19q codeletion, and ATRX mutation) are investigated. Additionally, we explore gender-specific effects on the radiogenomics-NB models. Finally, we compare the performance of the proposed three mutation prediction radiogenomics-NB models with different well-known methods in the literature: Negative Binomial Linear Discriminant Analysis (NBLDA), differentially expressed RNAseq with Random Forest (RF-genomics), radiomics and differentially expressed RNAseq with Random Forest (RF-radiogenomics), and Voom-based count transformation combined with the nearest shrinkage classifier (VoomNSC). Our analysis shows that the proposed radiogenomics-NB model significantly outperforms (ANOVA test, p < 0.05) for prediction of IDH and ATRX mutations and offers similar performance for prediction of 1p/19q codeletion, when compared to the competing models in the literature, respectively. Frontiers Media S.A. 2021-08-19 /pmc/articles/PMC8416908/ /pubmed/34490297 http://dx.doi.org/10.3389/fmed.2021.705071 Text en Copyright © 2021 Shboul, Diawara, Vossough, Chen and Iftekharuddin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Shboul, Zeina A.
Diawara, Norou
Vossough, Arastoo
Chen, James Y.
Iftekharuddin, Khan M.
Joint Modeling of RNAseq and Radiomics Data for Glioma Molecular Characterization and Prediction
title Joint Modeling of RNAseq and Radiomics Data for Glioma Molecular Characterization and Prediction
title_full Joint Modeling of RNAseq and Radiomics Data for Glioma Molecular Characterization and Prediction
title_fullStr Joint Modeling of RNAseq and Radiomics Data for Glioma Molecular Characterization and Prediction
title_full_unstemmed Joint Modeling of RNAseq and Radiomics Data for Glioma Molecular Characterization and Prediction
title_short Joint Modeling of RNAseq and Radiomics Data for Glioma Molecular Characterization and Prediction
title_sort joint modeling of rnaseq and radiomics data for glioma molecular characterization and prediction
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416908/
https://www.ncbi.nlm.nih.gov/pubmed/34490297
http://dx.doi.org/10.3389/fmed.2021.705071
work_keys_str_mv AT shboulzeinaa jointmodelingofrnaseqandradiomicsdataforgliomamolecularcharacterizationandprediction
AT diawaranorou jointmodelingofrnaseqandradiomicsdataforgliomamolecularcharacterizationandprediction
AT vossougharastoo jointmodelingofrnaseqandradiomicsdataforgliomamolecularcharacterizationandprediction
AT chenjamesy jointmodelingofrnaseqandradiomicsdataforgliomamolecularcharacterizationandprediction
AT iftekharuddinkhanm jointmodelingofrnaseqandradiomicsdataforgliomamolecularcharacterizationandprediction